期刊文献+

甲硝唑阴道原位凝胶质量控制研究 被引量:1

Quality Control of Metronidazole in-situ Vaginal Gel
原文传递
导出
摘要 目的:对制备的甲硝唑阴道原位凝胶的质量控制方法进行研究。方法:参照《中国药典》有关规定对原位凝胶的性状、鉴别、检查进行研究;采用高效液相色谱法测定甲硝唑的含量;对其稳定性及模拟生理条件下的流变学特性进行了初步考察。结果:所制备原位凝胶为无色或淡黄色透明液体,具有明显的温敏相变特性。鉴别、检查均符合2005年版《中国药典》中的相关规定;HPLC法检测甲硝唑浓度的线性范围为5.0~30.0μg·ml^(-1)(r=0.999 9),平均回收率分别为99.4%(RSD=0.7%)。稳定性试验中性状、pH及含量在考察期内无明显变化,胶凝温度及胶凝时间变异系数分别小于5%和8%。模拟生理条件下胶凝温度有所提高,黏附力有所降低。结论:筛选出的原位凝胶处方可行,制备工艺简单,质量稳定可控。进行原位凝胶质量控制时应对生理条件下的流变学特性进行评价和控制。 Objective : To study on quality control method of metronidazole in-situ vaginal gel. Method : The appearance, identification and test of metronidazole in-situ vaginal gel was studied and described. The determination of metronidazole was performed with HPLC. The stability of in-situ gel and rheological properties under simulated physiological condition were investigated preliminarily. Result : The prepared in-situ gel was colorless or yellowish limpid liquid with character of reverse phase transformation. Its test and identification results were in conformity with the related stipulation of China Pharmacopeia ( 2005 edition). The linear range of metronidazole was 5.0 -30.0μg · ml^-1( r = 0. 999 9), and the average recovery was 99.4% (RSD = 0.7% ). There was no significant change for indexes in the accelerated test and sample test. RSD of gelation temperature and gelation time during stability test were less than 5% and 8% , respectively. The gelation temperature became high and bioadhesive force was reduced under simulated physiological condition. Conclusion: The quality of metronidazole in-situ vaginal gel is stable and controllable, and variation of theological properties under simulated physiological condition should be taken into account.
出处 《中国药师》 CAS 2009年第7期855-857,共3页 China Pharmacist
基金 深圳市科技计划(医疗卫生类)项目(编号:200703218)
关键词 甲硝唑 原位凝胶 质量控制 Metronidazole In-situ gel Quality Control
  • 相关文献

参考文献7

二级参考文献38

  • 1唐星,王成伟.常用生物黏附性高分子材料物理性质的比较试验[J].中国药学杂志,2005,40(5):361-364. 被引量:12
  • 2刘刚,汤晴,张捷,王海涛,姜韧,谭生建.氯霉素甲硝唑洗鼻剂的含量测定及其有关物质检查方法[J].解放军药学学报,2005,21(5):383-386. 被引量:2
  • 3张翠霞,张文涛,王东凯,仲静洁,徐飒.新型的药物传递系统-原位凝胶的研究进展[J].中国医院药学杂志,2006,26(4):459-461. 被引量:42
  • 4徐玉红,李东,王蔓琳,李玉珍,何文.壳聚糖对温敏性原位凝胶基质体外流变学特性的影响[J].中国药业,2007,16(13):4-5. 被引量:13
  • 5Kakoulides EP,Smart JD,Tsibouklis J.Azocrosslinked poly (acrylic acid) for colonic delivery and adhesion specificity:in vitro degradation and preliminary ex vivo bioadhesion studies[J].J Controlled Release,1998,54 (1):95-109.
  • 6Moore LA,Norton RL,Whtman SL,et al.An injectable biodegradable drug delivery system based on acrylic terminated poly e-caprolactone,The 21^st Annual Meeting of the Society of Biomaterials,CA,1995.
  • 7Cui H,Messermith PB.Tailored Polymeric Materials For Controlled Delivery Systems[M].Washington,DC:American Chemical Society,1998.203-211.
  • 8Jeong B,Kim SW,Bae YH.Thermosensitive sol-gel reversible hydrogels[J].Advanced Drug Delilvery Reviews,2002,54(1):37-51.
  • 9Cohen S,lobel E,Trevgoda A,et al.A novel in-situ forming drug delivery system from alginates undergoing gelation in the eye[J].J Controlled Release,1997,44(2-3):201-208.
  • 10Miyazaki S,Kubo W,Attwood D.Oral sustained delivery of theophylline using in-situ gelation of sodium alginate[J].J Controlled Release,2000,67 (2-3):275-280.

共引文献447

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部